Thank you to The ASCO Post: Is #MaleBreastCancer Overlooked in Clinical Trials? –
Story: Is Male Breast Cancer Overlooked in Clinical Trials? – The ASCO Post I want to thank the ASCO Post for running this story – it is much appreciated!
research
Thank you #ASBrS for the chance to speak about clinical trials for #malebreastcancer
Yesterday I was honored to speak at a session on Clinical Trials at the annual meeting of the American Society of Breast Surgeons in Dallas. Dr. Deanna Attai, the President of ASBrS and a breast […]
Differences between #malebreastcancer and female breast cancers identified
Exciting news today from the 10th European Breast Cancer Conference! Here is a quote from today’s exciting announcement/presentation about the biology of male breast cancer: Speaking at the 10th European Breast Cancer Conference (EBCC-10) today (Thursday), […]
Hormone-deprivation therapy leads to mutations in estrogen receptor in #breastcancer – new insights summarized by Alluri et al
Estrogen receptor mutations and their role in breast cancer progression Prasanna G Alluri, Corey Speers and Arul M Chinnaiyan Breast Cancer Research 2014, 16:494 doi:10.1186/s13058-014-0494-7 Background About 75% of breast cancers are hormone positive, and […]
Hormone therapy for transgender treatment doesn’t increase risk for #breastcancer or #malebreastcancer according to Brown and Jones
Incidence of breast cancer in a cohort of 5,135 transgender veterans George R. Brown and Kenneth T. Jones Breast Cancer Res Treat DOI 10.1007/s10549-014-3213-2 Background Most breast cancers are hormone driven, at least at first, […]
Misclassification of sex in cancer registries: we may not know how many men get #breastcancer #malebreastcancer
Misclassification of Sex in Central Cancer Registries Recinda L. Sherman, MPH, PhD, CTR; Francis P. Boscoe, PhD; David K. O’Brien, PhD, GISP; Justin T. George, MPH; Kevin A. Henry, PhD; Laura E. Soloway, PhD; David […]
More extensive mutation study of familial #MaleBreastCancer by Deb et al shows subtypes, similarity to women
Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations S Deb, S Q Wong1, J Li, H Do, J Weiss, D Byrne, A Chakrabarti, T […]
Why sleeping in the dark may be critical to #breastcancer patients on endocrine therapy according to Dauchy et al #bcsm
Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to Tamoxifen Therapy in Breast Cancer Robert T. Dauchy, Shulin Xiang, Lulu Mao, Samantha Brimer, Melissa A. Wren, Lin Yuan, Muralidharan Anbalagan, […]
#malebreastcancer in Chinese men is similar to that of men elsewhere according to Zhou et al
Male breast carcinoma: a clinicopathological and immunohistochemical characterization study Zhou et al., Int J Clin Exp Pathol 2014;7(10):6852-6861 Background A good baseline study of any disease group is a retrospective analysis based on hospital records or […]
Familial #malebreastcancer cluster together by microRNA expression – Danza et al 2014 use 30% male samples!
(I have decided to try, from time to time, to write about new publications in research on male breast cancer, and give a brief lay explanation of the findings and perhaps a comment. Here goes.) […]
